These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 28427234)
1. Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C. Huang CF; Huang CI; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML Oncotarget; 2017 May; 8(20):32618-32625. PubMed ID: 28427234 [TBL] [Abstract][Full Text] [Related]
2. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication. Huang CF; Wang SC; Yeh ML; Huang CI; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Chen A; Yu ML J Gastroenterol Hepatol; 2019 Jan; 34(1):249-255. PubMed ID: 29932235 [TBL] [Abstract][Full Text] [Related]
3. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment. Huang CF; Huang CY; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720 [TBL] [Abstract][Full Text] [Related]
4. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma. Kumar V; Yi Lo PH; Sawai H; Kato N; Takahashi A; Deng Z; Urabe Y; Mbarek H; Tokunaga K; Tanaka Y; Sugiyama M; Mizokami M; Muroyama R; Tateishi R; Omata M; Koike K; Tanikawa C; Kamatani N; Kubo M; Nakamura Y; Matsuda K PLoS One; 2012; 7(9):e44743. PubMed ID: 23024757 [TBL] [Abstract][Full Text] [Related]
5. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample. Augello G; Balasus D; Fusilli C; Mazza T; Emma MR; Giannitrapani L; Agliastro R; Cervello M; Montalto G OMICS; 2018 Apr; 22(4):274-282. PubMed ID: 29584564 [TBL] [Abstract][Full Text] [Related]
6. A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. Sharkawy RE; Bayoumi A; Metwally M; Mangia A; Berg T; Romero-Gomez M; Abate ML; Irving WL; Sheridan D; Dore GJ; Spengler U; Lampertico P; Bugianesi E; Weltman M; Mollison L; Cheng W; Riordan S; Santoro R; Gallego-Durán R; Fischer J; Nattermann J; D'Ambrosio R; McLeod D; Powell E; Latchoumanin O; Thabet K; Najim MAM; Douglas MW; Liddle C; Qiao L; George J; Eslam M; Sci Rep; 2019 Feb; 9(1):1439. PubMed ID: 30723271 [TBL] [Abstract][Full Text] [Related]
7. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection. Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210 [TBL] [Abstract][Full Text] [Related]
8. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis. Luo X; Wang Y; Shen A; Deng H; Ye M BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949 [TBL] [Abstract][Full Text] [Related]
9. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients. Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040 [TBL] [Abstract][Full Text] [Related]
10. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients. Marangon CG; de Bitencorte JT; Michita RT; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D Pathol Oncol Res; 2020 Jul; 26(3):1519-1525. PubMed ID: 31471884 [TBL] [Abstract][Full Text] [Related]
11. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. Lange CM; Bibert S; Dufour JF; Cellerai C; Cerny A; Heim MH; Kaiser L; Malinverni R; Müllhaupt B; Negro F; Semela D; Moradpour D; Kutalik Z; Bochud PY; J Hepatol; 2013 Sep; 59(3):504-9. PubMed ID: 23665287 [TBL] [Abstract][Full Text] [Related]
12. Associations between MICA and MICB Genetic Variants, Protein Levels, and Colorectal Cancer: Atherosclerosis Risk in Communities (ARIC). Wang S; Onyeaghala GC; Pankratz N; Nelson HH; Thyagarajan B; Tang W; Norby FL; Ugoji C; Joshu CE; Gomez CR; Couper DJ; Coresh J; Platz EA; Prizment AE Cancer Epidemiol Biomarkers Prev; 2023 Jun; 32(6):784-794. PubMed ID: 36958849 [TBL] [Abstract][Full Text] [Related]
13. Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes. Huang CI; Huang CF; Yeh ML; Lin YH; Liang PC; Liu SV; Hsieh MH; Lin ZY; Chen SC; Huang JF; Chuang WL; Dai CY; Yu ML Medicine (Baltimore); 2018 Mar; 97(10):e9782. PubMed ID: 29517696 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma. Hai H; Tamori A; Thuy LTT; Yoshida K; Hagihara A; Kawamura E; Uchida-Kobayashi S; Morikawa H; Enomoto M; Murakami Y; Kawada N Sci Rep; 2017 Sep; 7(1):11912. PubMed ID: 28928439 [TBL] [Abstract][Full Text] [Related]
15. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk. Lo PH; Urabe Y; Kumar V; Tanikawa C; Koike K; Kato N; Miki D; Chayama K; Kubo M; Nakamura Y; Matsuda K PLoS One; 2013; 8(4):e61279. PubMed ID: 23593449 [TBL] [Abstract][Full Text] [Related]
17. DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection. Burza MA; Motta BM; Mancina RM; Pingitore P; Pirazzi C; Lepore SM; Spagnuolo R; Doldo P; Russo C; Lazzaro V; Fischer J; Berg T; Aghemo A; Cheroni C; De Francesco R; Fargion S; Colombo M; Datz C; Stickel F; Valenti L; Romeo S Hepatology; 2016 Feb; 63(2):418-27. PubMed ID: 26517016 [TBL] [Abstract][Full Text] [Related]
18. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population. Mariaselvam CM; Boukouaci W; Charron D; Krishnamoorthy R; Tamouza R; Misra DP; Negi VS Int J Rheum Dis; 2018 Mar; 21(3):656-663. PubMed ID: 28752674 [TBL] [Abstract][Full Text] [Related]
19. Lower protein expression levels of MHC class I chain-related gene A in hepatocellular carcinoma are at high risk of recurrence after surgical resection. Huang CF; Wang SC; Chang WT; Yeh ML; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Chen YL; Yu ML Sci Rep; 2018 Oct; 8(1):15821. PubMed ID: 30361527 [TBL] [Abstract][Full Text] [Related]
20. [The relationship between major histocompatibility complex class I chain-related antigens A (MICA)-129 gene polymorphism, soluble MICA level and ulcerative colitis]. Zhao J; Jiang Y; Lei Y; Chen LP; Yi FM; Wang CG; Zou KF; Xia B Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):311-5. PubMed ID: 21600151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]